drugset / Trial / NCT05691660
A Study of TAS3731 in Healthy Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety of single and repeated administration of TAS3731.
Timeline
- Start
- 2023-01-17
- Primary completion
- 2024-05-21
- Completion
- 2024-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAS3731 | Unknown | — | Oral |
Indications
No indication recorded.